James Shin
Stock Analyst at Deutsche Bank
(1.92)
# 2,949
Out of 4,873 analysts
20
Total ratings
44.44%
Success rate
4.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMTX Immatics | Initiates: Buy | $10 | $5.47 | +82.82% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $105.93 | +13.28% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $79.67 | +31.79% | 2 | Feb 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,025 → $1,015 | $792.30 | +28.11% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $280.35 | +8.79% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $67.55 | -11.18% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $46.68 | -3.60% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $33.43 | +79.48% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $185.39 | -19.09% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $520.29 | +53.76% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.32 | +331.03% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.81 | +1,390.13% | 1 | Nov 9, 2023 |
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $5.47
Upside: +82.82%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $105.93
Upside: +13.28%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $79.67
Upside: +31.79%
Eli Lilly and Company
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $792.30
Upside: +28.11%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $280.35
Upside: +8.79%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $67.55
Upside: -11.18%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $46.68
Upside: -3.60%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $33.43
Upside: +79.48%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $185.39
Upside: -19.09%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $520.29
Upside: +53.76%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.32
Upside: +331.03%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.81
Upside: +1,390.13%